Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip M Potter

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Biological Chemistry|January 1, 2008
Evaluation of the 'side door' in carboxylesterase-mediated catalysis and inhibitionTimothy M Streit, Abdolsamad Borazjani, Shellaine E Lentz, et al.
Molecular Cancer Therapeutics|August 10, 2004
Characterization of inhibitors of specific carboxylesterases: development of carboxylesterase inhibitors for translational applicationKyoung Jin P Yoon, Janice L Hyatt, Christopher L Morton, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2018
Targeting ALK in pediatric RMS does not induce antitumor activity in vivoMonika Wierdl, Lyudmila Tsurkan, Liying Chi, et al.
Journal of Molecular Biology|September 12, 2006
Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1Sompop Bencharit, Carol C Edwards, Christopher L Morton, et al.
Biochemistry|April 5, 2007
Crystal structures of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and tabunChristopher D Fleming, Carol C Edwards, Stephen D Kirby, et al.
Journal of Medicinal Chemistry|January 5, 2008
Identification of human intestinal carboxylesterase as the primary enzyme for activation of a doxazolidine carbamate prodrugBenjamin L Barthel, Renee C Torres, Janice L Hyatt, et al.
Chemico-Biological Interactions|November 18, 2005
The 3D structure of the anticancer prodrug CPT-11 with Torpedo californica acetylcholinesterase rationalizes its inhibitory action on AChE and its hydrolysis by butyrylcholinesterase and carboxylesteraseMichal Harel, Janice L Hyatt, Boris Brumshtein, et al.
Journal of Natural Products|January 5, 2013
Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen")M Jason Hatfield, Lyudmila G Tsurkan, Janice L Hyatt, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 11, 2012
High payload dual therapeutic-imaging nanocarriers for triggered tumor deliveryJin-Ki Kim, Hong Yuan, Jingxin Nie, et al.
Pharmacology Research & Perspectives|July 15, 2015
Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidatesYihui Shi, Amanda S Joyner, William Shadrick, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Biological Chemistry|January 1, 2008
Evaluation of the 'side door' in carboxylesterase-mediated catalysis and inhibitionTimothy M Streit, Abdolsamad Borazjani, Shellaine E Lentz, et al.
Molecular Cancer Therapeutics|August 10, 2004
Characterization of inhibitors of specific carboxylesterases: development of carboxylesterase inhibitors for translational applicationKyoung Jin P Yoon, Janice L Hyatt, Christopher L Morton, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2018
Targeting ALK in pediatric RMS does not induce antitumor activity in vivoMonika Wierdl, Lyudmila Tsurkan, Liying Chi, et al.
Journal of Molecular Biology|September 12, 2006
Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1Sompop Bencharit, Carol C Edwards, Christopher L Morton, et al.
Biochemistry|April 5, 2007
Crystal structures of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and tabunChristopher D Fleming, Carol C Edwards, Stephen D Kirby, et al.
Journal of Medicinal Chemistry|January 5, 2008
Identification of human intestinal carboxylesterase as the primary enzyme for activation of a doxazolidine carbamate prodrugBenjamin L Barthel, Renee C Torres, Janice L Hyatt, et al.
Chemico-Biological Interactions|November 18, 2005
The 3D structure of the anticancer prodrug CPT-11 with Torpedo californica acetylcholinesterase rationalizes its inhibitory action on AChE and its hydrolysis by butyrylcholinesterase and carboxylesteraseMichal Harel, Janice L Hyatt, Boris Brumshtein, et al.
Journal of Natural Products|January 5, 2013
Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen")M Jason Hatfield, Lyudmila G Tsurkan, Janice L Hyatt, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 11, 2012
High payload dual therapeutic-imaging nanocarriers for triggered tumor deliveryJin-Ki Kim, Hong Yuan, Jingxin Nie, et al.
Pharmacology Research & Perspectives|July 15, 2015
Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidatesYihui Shi, Amanda S Joyner, William Shadrick, et al.
Pageof 9